A

Acticor Biotech SA
PAR:ALACT

Watchlist Manager
Acticor Biotech SA
PAR:ALACT
Watchlist
Price: 0.4 EUR -2.44% Market Closed
Market Cap: 6.3m EUR
Have any thoughts about
Acticor Biotech SA?
Write Note

Acticor Biotech SA
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Acticor Biotech SA
Accounts Receivables Peer Comparison

Comparables:
VLA
NANO
G
GNFT
ALERS
OSE

Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
A
Acticor Biotech SA
PAR:ALACT
Accounts Receivables
€778k
CAGR 3-Years
7%
CAGR 5-Years
-10%
CAGR 10-Years
-21%
Valneva SE
PAR:VLA
Accounts Receivables
€30.5m
CAGR 3-Years
19%
CAGR 5-Years
17%
CAGR 10-Years
23%
Nanobiotix SA
PAR:NANO
Accounts Receivables
€3m
CAGR 3-Years
N/A
CAGR 5-Years
117%
CAGR 10-Years
N/A
G
Genfit SA
PAR:GNFT
Accounts Receivables
€61.5m
CAGR 3-Years
380%
CAGR 5-Years
83%
CAGR 10-Years
90%
Eurobio Scientific SA
PAR:ALERS
Accounts Receivables
€27m
CAGR 3-Years
-15%
CAGR 5-Years
11%
CAGR 10-Years
17%
OSE Immunotherapeutics SA
PAR:OSE
Accounts Receivables
€5m
CAGR 3-Years
89%
CAGR 5-Years
33%
CAGR 10-Years
N/A

See Also

What is Acticor Biotech SA's Accounts Receivables?
Accounts Receivables
778k EUR

Based on the financial report for Dec 31, 2023, Acticor Biotech SA's Accounts Receivables amounts to 778k EUR.

What is Acticor Biotech SA's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
-21%

Over the last year, the Accounts Receivables growth was -38%. The average annual Accounts Receivables growth rates for Acticor Biotech SA have been 7% over the past three years , -10% over the past five years , and -21% over the past ten years .

Back to Top